Developer docs
API playgroundTry for free, no card

Search company profiles

codon one

Full company profile

uuid02mg4wi

Namestring
codon one
Legal namestring
Codon One, BV
Websiteurl
codon.one
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Codon One, BV is a Leuven, Belgium-based genomics software company developing AI-driven tools for clinical genome interpretation. Its flagship product, Arun, launched in November 2025 and is positioned as the first software platform purpose-built for fully automated genome reanalysis of archived whole exome sequencing (WES) and whole genome sequencing (WGS) data. Arun uses advanced language models to extract phenotypes from clinical notes and build structured Human Phenotype Ontology (HPO) profiles, then continuously reinterprets variants against the latest gene-disease insights and ACMG clinical guidelines. The platform analyzes an exome in under one minute and a whole genome in under five minutes — roughly 100x faster than legacy interpretation tools — and self-evaluates case-level confidence to flag only high-probability diagnoses for human review. In a pilot at Antwerp University Hospital led by Prof. Bart Loeys, Arun ranked the causal variant in the top 3 in 99% of solved cases with an average of 4.8 prioritized variants per case and reduced manual review burden by 50%.

Short descriptiontext

Codon One is a Leuven-based genomics software company whose Arun platform uses AI language models to automatically reanalyze archived WES/WGS data, helping clinical genetics laboratories and hospitals diagnose rare disease patients faster.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLeuven, Belgium
HQ citystring
Leuven
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genome reanalysis software, clinical genomics diagnostics, rare disease diagnostics, variant interpretation platform, WES WGS analysis
Industry2 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Clinical Genomics Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software Platform Subscription
TypeSubscription Recurring
Description

Arun is offered as a software-as-a-service platform with free trial access. Labs sign up through the self-serve portal and likely pay subscription fees for ongoing access to automated reanalysis capabilities.

codon.one
2Enterprise Licensing
TypeSubscription Recurring
Description

Direct enterprise licensing to clinical genetics centers and hospitals for clinical diagnostics use, evidenced by pilot study partnerships with academic medical centers.

codon.one
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Free trial access
ModelFreemiumBilling cadenceMonthly
Notes

Users can sign up and run their first analysis for free. No pricing tiers or paid plans are publicly disclosed.

codon.one
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Arun
Description

The world's first software platform built specifically for fully automated genome reanalysis. Arun continuously re-examines archived genomic data using the latest gene-disease insights, updated variant classifications, and evolving phenotypic information. Capable of analyzing an exome in under one minute and a whole genome in under five minutes.

codon.one
Core offering1 text field

Codon One develops Arun, a software platform that performs fully automated reanalysis of archived whole exome and whole genome sequencing data for clinical genetics labs. The platform extracts phenotypes from clinical notes using language models, prioritizes likely causal variants, and reinterprets cases continuously as new gene-disease knowledge emerges, enabling hospital labs to deliver rare disease diagnoses without manual intervention.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 99% of solved cases with causal variant in top 3 prioritized variants
+4 more records
Product overview1 text field

Codon One offers a unified product portfolio centered on genomic analysis software for rare disease diagnostics. The primary product is Arun, the world's first fully automated genome reanalysis platform that reinterprets archived WES/WGS data using the latest clinical insights. The company also built and later sold Moon, the pioneering AI-driven rare disease diagnostic software, through its predecessor company Diploid. Arun represents the next generation of this technology, engineered specifically for the genomic era where WGS is routine.

Product and service1 record
1Arun
CategoryGenome reanalysis software
Description

Arun is a SaaS platform that performs fully automated reanalysis of archived WES/WGS data for clinical genetics centers and hospital diagnostic labs. It automatically extracts phenotypes from clinical notes, builds structured HPO profiles, reinterprets variants, and prioritizes likely causal diagnoses, with an exome analyzed in under one minute and a whole genome in under five minutes.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Antwerp University Hospital / Centre of Medical Genetics
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Antwerp University Hospital served as the primary pilot study partner for validating Arun's automated genome reanalysis capabilities. Prof. Bart Loeys from the Centre of Medical Genetics led the validation, demonstrating 99% accuracy with causal variants in top 3. This partnership provided clinical validation critical for product development and market positioning.

codon.one
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

codon one

Clinical Genomics Softwarecodon.one

Codon One is a Leuven-based genomics software company whose Arun platform uses AI language models to automatically reanalyze archived WES/WGS data, helping clinical genetics laboratories and hospitals diagnose rare disease patients faster.

What codon one does

Codon One, BV is a Leuven, Belgium-based genomics software company developing AI-driven tools for clinical genome interpretation. Its flagship product, Arun, launched in November 2025 and is positioned as the first software platform purpose-built for fully automated genome reanalysis of archived whole exome sequencing (WES) and whole genome sequencing (WGS) data. Arun uses advanced language models to extract phenotypes from clinical notes and build structured Human Phenotype Ontology (HPO) profiles, then continuously reinterprets variants against the latest gene-disease insights and ACMG clinical guidelines. The platform analyzes an exome in under one minute and a whole genome in under five minutes — roughly 100x faster than legacy interpretation tools — and self-evaluates case-level confidence to flag only high-probability diagnoses for human review. In a pilot at Antwerp University Hospital led by Prof. Bart Loeys, Arun ranked the causal variant in the top 3 in 99% of solved cases with an average of 4.8 prioritized variants per case and reduced manual review burden by 50%.

codon one firmographics

Firmographics
Name
codon one
Legal name
Codon One, BV
Website
https://codon.one
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
Codon One is a Leuven-based genomics software company whose Arun platform uses AI language models to automatically reanalyze archived WES/WGS data, helping clinical genetics laboratories and hospitals diagnose rare disease patients faster.
Ownership category
akta.pro rank

codon one industry classification

Industry
Product category
Clinical Genomics Software
NAICS
Software Publishers (5132)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Genome reanalysis software
  • Clinical genomics diagnostics
  • Rare disease diagnostics
  • Variant interpretation platform
  • WES WGS analysis

Where codon one is headquartered

Location

Headquarters

HQ city
Leuven
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

codon one business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Software Platform Subscription: Arun is offered as a software-as-a-service platform with free trial access. Labs sign up through the self-serve portal and likely pay subscription fees for ongoing access to automated reanalysis capabilities.
  2. Enterprise Licensing: Direct enterprise licensing to clinical genetics centers and hospitals for clinical diagnostics use, evidenced by pilot study partnerships with academic medical centers.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree trial access

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

codon one product offering

Product offering

Core offering

Codon One develops Arun, a software platform that performs fully automated reanalysis of archived whole exome and whole genome sequencing data for clinical genetics labs. The platform extracts phenotypes from clinical notes using language models, prioritizes likely causal variants, and reinterprets cases continuously as new gene-disease knowledge emerges, enabling hospital labs to deliver rare disease diagnoses without manual intervention.

Product overview

Codon One offers a unified product portfolio centered on genomic analysis software for rare disease diagnostics. The primary product is Arun, the world's first fully automated genome reanalysis platform that reinterprets archived WES/WGS data using the latest clinical insights. The company also built and later sold Moon, the pioneering AI-driven rare disease diagnostic software, through its predecessor company Diploid. Arun represents the next generation of this technology, engineered specifically for the genomic era where WGS is routine.

Differentiator

Problem solved

Functional benefit

Brands

  • Arun: The world's first software platform built specifically for fully automated genome reanalysis. Arun continuously re-examines archived genomic data using the latest gene-disease insights, updated variant classifications, and evolving phenotypic information. Capable of analyzing an exome in under one minute and a whole genome in under five minutes.

Products and services

  • Arun Arun is a SaaS platform that performs fully automated reanalysis of archived WES/WGS data for clinical genetics centers and hospital diagnostic labs. It automatically extracts phenotypes from clinical notes, builds structured HPO profiles, reinterprets variants, and prioritizes likely causal diagnoses, with an exome analyzed in under one minute and a whole genome in under five minutes.

Quantifiable outcome

  • 99% of solved cases with causal variant in top 3 prioritized variants
  • +4 more outcomes

Companies that use codon one

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

codon one technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

codon one partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Antwerp University Hospital / Centre of Medical GeneticscoreStrategic or Co-development Partner · 1 January 2025Antwerp University Hospital served as the primary pilot study partner for validating Arun's automated genome reanalysis capabilities. Prof. Bart Loeys from the Centre of Medical Genetics led the validation, demonstrating 99% accuracy with causal variants in top 3. This partnership provided clinical validation critical for product development and market positioning.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

codon one competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat4 records

Customer concentration

codon one social profiles

Digital presence

codon one financial estimates

Financial estimate

Revenue estimate

Valuation estimate

codon one leadership team

Management profile

Number of profiles

Profiles1 record

codon one funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

codon one M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about codon one

What does codon one do?

Codon One develops Arun, a software platform that performs fully automated reanalysis of archived whole exome and whole genome sequencing data for clinical genetics labs. The platform extracts phenotypes from clinical notes using language models, prioritizes likely causal variants, and reinterprets cases continuously as new gene-disease knowledge emerges, enabling hospital labs to deliver rare disease diagnoses without manual intervention.

Is codon one a public or private company?

codon one is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was codon one founded?

codon one was founded in 2023. It employs 1 to 10 people.

Where is codon one based?

codon one is headquartered in Leuven, Belgium, in the Europe region.

How does codon one make money?

Two revenue lines are on record. Software Platform Subscription is the primary driver. The others are enterprise Licensing.

Does codon one have an API?

No public API is recorded for codon one.

What industry is codon one in?

codon one's product category is Clinical Genomics Software. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 5132 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales